相关实验视频
Updated: Jun 8, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
STIM1通过通过TFEB核转位的自活化促进子宫癌的进展
Xi Luo1, Mengchan Jian2, Ping Wu3
1Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan 442000, China; Department of Gynecology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, China.
流体相互作用分子1 (STIM1) 通过增强自和TFEB核转移促进子宫癌的进展. 抑制STIM1可能为宫癌提供一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 自对于细胞内稳定性至关重要;其失调与癌症有关.
- 流体相互作用分子1 (STIM1) 在癌症自中的作用及其临床意义尚不清楚.
研究的目的:
- 研究STIM1对子宫癌的影响和机制.
- 确定STIM1作为宫癌的潜在分子治疗点.
主要方法:
- 在宫癌组织中分析STIM1,TFEB和与自相关的蛋白质.
- 在体外实验中使用SiHa细胞来抑制STIM1介导的进入和TFEB通路.
- 评估自流和STIM1的淘汰效应.
主要成果:
- STIM1,TFEB和自蛋白水平与子宫癌进展有积极的相关性.
- 抑制STIM1介导的进入减少了癌细胞的增殖和迁移,促进了细胞亡.
- STIM1倒置抑制了自和TFEB核转位.
结论:
- 通过增强的TFEB核转位,STIM1促进了自和宫癌的进展.
- STIM1代表了宫癌治疗的潜在治疗标.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
TGF - β Signaling Pathway
The Intrinsic Apoptotic Pathway
Induced Pluripotent Stem Cells
Somatic...
PI3K/mTOR/AKT Signaling Pathway